JPH02220662A - Disinfection of injection needle - Google Patents

Disinfection of injection needle

Info

Publication number
JPH02220662A
JPH02220662A JP1043457A JP4345789A JPH02220662A JP H02220662 A JPH02220662 A JP H02220662A JP 1043457 A JP1043457 A JP 1043457A JP 4345789 A JP4345789 A JP 4345789A JP H02220662 A JPH02220662 A JP H02220662A
Authority
JP
Japan
Prior art keywords
injection needle
alcohol
disinfection
container
used injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1043457A
Other languages
Japanese (ja)
Inventor
Naomasa Nomura
野村 直正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP1043457A priority Critical patent/JPH02220662A/en
Publication of JPH02220662A publication Critical patent/JPH02220662A/en
Pending legal-status Critical Current

Links

Landscapes

  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

PURPOSE:To reuse an injection needle by a method wherein a used injection needle is immersed in alcohol to be hermetically closed in a container and alcohol is boiled. CONSTITUTION:A used injection needle is immersed in alcohol and a container is hermetically closed to boil alcohol for several min to several hr under heating. By this simple operation, the used injection needle can be perfectly disinfected to be reused and, therefore, medical expenses can be also reduced.

Description

【発明の詳細な説明】 (産業上の利用分野) 医りょう関係 (従来の技術) 使用後はすてていた (発明が解決しようとする課題) 注射バリを再度使用出来る様にする (課題を解決するための手段) 使用した注射バリをアルコールの中に入れ容器をみっぺ
いし加熱させて数十分又は数時間ふっとうさせて消どく
し注射バリを再度使用出来る様にする (発明の効果・作用) ・医りょう費のコストダウン ・注射バリの再利用
[Detailed description of the invention] (Industrial field of application) Medicine-related (prior art) Discarded after use (problem to be solved by the invention) Making injection burrs usable again (problem to be solved) Measures to solve the problem) Put the used injection burr in alcohol, thoroughly heat the container, and let it simmer for several minutes or several hours to extinguish it and make the injection burr usable again. Effect) ・Cost reduction of medical expenses ・Reuse of injection burrs

Claims (1)

【特許請求の範囲】[Claims] 使用した注射バリをアルコールの中に入れて容器をみっ
ぺいしふっとうさせて注射バリを消どくし再度使用する
様にする
Place the used injection burr in alcohol and make the container fluffy to erase the injection burr and use it again.
JP1043457A 1989-02-22 1989-02-22 Disinfection of injection needle Pending JPH02220662A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1043457A JPH02220662A (en) 1989-02-22 1989-02-22 Disinfection of injection needle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1043457A JPH02220662A (en) 1989-02-22 1989-02-22 Disinfection of injection needle

Publications (1)

Publication Number Publication Date
JPH02220662A true JPH02220662A (en) 1990-09-03

Family

ID=12664234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1043457A Pending JPH02220662A (en) 1989-02-22 1989-02-22 Disinfection of injection needle

Country Status (1)

Country Link
JP (1) JPH02220662A (en)

Similar Documents

Publication Publication Date Title
ATE159661T1 (en) MEDICINE FOR DISINFECTION OF THE ORAL CAVITY
ATA123791A (en) METHOD FOR PRODUCING AN INACTIVATED BLOOD PRODUCT
DE69026112D1 (en) NON-OXIDIZING OPHTHALMIC COMPOSITIONS AND METHODS FOR THE PRESERVATION AND APPLICATION
DE69003652T2 (en) USE OF C-22 TO C-26 ALIPHATIC ALCOHOLS FOR THE TREATMENT OF FLAMMABLE AND VIRAL SKIN DISEASES.
DE69309492T2 (en) ANTIPYRETIC AND ANALGETIC COMPOSITIONS CONTAINING OPTICALLY PURE R-KETOROLAC
DE69202019D1 (en) Use of essential fatty acids in the manufacture of a medicament for the treatment of AIDS.
DE69116380D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING EXTENDED COAGLING TIME
ES493359A0 (en) PROCEDURE FOR THE PREPARATION OF A COLAGE-NO SOLUTION
SE8902565D0 (en) PREPARE FOR PREPARING A BEFORE IMPLEMENTATION DEDICATED IMPLANT BODY
DE59600683D1 (en) Use of trospium chloride in the manufacture of a medicament for the treatment of bladder diseases
DE69305267T2 (en) Composition for the treatment of mastitis and metritis
DE69005062D1 (en) Fatty acids for the treatment and prevention of skin damage through radiotherapy.
SE8801710D0 (en) NEW OPHTALMOLOGICAL COMPOSITION OF MATTER
JPH02220662A (en) Disinfection of injection needle
HUT61199A (en) Process for producing pharmaceutical compositions suitable for treating hyperlipidaemia and/or atherosclerosis
DE69132737T2 (en) METHOD FOR TREATING WOOL
ES2163528T3 (en) A WATERPROOF SOLUTION FOR INFUSION, STABLE TO STORAGE, CONTAINING A THROMBIN INHIBITOR.
DE69026511T2 (en) USE OF GIBBERELLINES FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING PROSTATITIS
DE69511453D1 (en) Use of a combination of antineoplastons for the manufacture of a medicament for the treatment of neurofibromatosis
DE2507353A1 (en) Automatic contact lens cleaning appts - with cleaning liq vibrated ultrasonically and heated to sterilisation
ATE178336T1 (en) USE OF A THERAPEUTIC COMPOSITION FOR TREATING BRONCHITIS
DE69516602T2 (en) Use of bifemelan in the manufacture of a medicament for the treatment of hyperkinesia
Thankachan et al. Comparative efficacy of three deproteinizing agents on the shear bond strength of pit and fissure sealant: An: in vitro: study
DE3585312D1 (en) APPLICATION OF 1,6-DIMETHYL-4-OXO-1,6,7,8,9A-HEXAHYDRO-4H-PYRIDO (1,2-A) PYRIMIDIN-3-CARBOXAMIDE FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DAMAGE.
DE69210737T2 (en) Use of L-2-oxothiazolidine-4-carboxylates for the manufacture of a medicament for the treatment of latent HIV infections